Clavulox 50mg (per tablet)
Clavulanic Acid 10mg
This is a prescription medicine. A prescription is required from your veterinarian before we can supply this product. Please ensure that you have read the "How to Order" page before ordering this item.
All of our products are APVMA or TGA approved and identical to those used by your veterinarian. Please call or email us if you have any queries about any of the products on our site.
|Drug Name and Strength||Amoxycillin 40mg,
Clavulanic Acid 10mg
|Indication||Diseases of cats and dogs including skin diseases (including deep and superficial pyodermas), urinary tract infections, respiratory diseases (involving upper and lower respiratory tract), enteritis.|
|Contraindications||Administration to small herbivores, e.g. rabbits or guinea pigs. History of allergic reactions to penicillins.|
|Actions||Microbiology Resistance to many antibiotics is caused by β-lactamase enzymes which destroy the antibiotic before it can act on the bacteria. The clavulanate counteracts this defence mechanism by inactivating the β-lactamases, thus rendering the organisms sensitive to amoxycillin's rapid bactericidal effect at concentrations readily attainable in the body. In vitro, Clavulox is active against a wide range of clinically important bacteria, including Gram-positive: Staphylococci (including β-lactamase producing strains), Corynebacteria, Streptococci; Gram-negative: Escherichia coli (including β-lactamase producing strains), Bordetella bronchiseptica, Proteus mirabilis, Salmonella sp. (including β-lactamase producing strains), Pasteurella and Klebsiella.Clavulox is not indicated for cases involving Pseudomonas sp.|
|Dosage and Administration||A standard dose rate of 12.5 mg/kg bodyweight twice daily is recommended, by oral administration only. Tablets are often accepted from the hand; alternatively they may be crushed and added to a little food. This dose has proved effective in the majority of infections, including those of the skin, urinary tract and gastrointestinal tract. Refractory cases, particularly those of the respiratory tract, have shown improved cure rates by doubling the dose to 25 mg/kg bodyweight twice daily.For routine cases involving all indications continue therapy for five to seven days or for 48 hours after all symptoms have subsided. In chronic or refractory cases where there is considerable tissue damage, a longer course of therapy may be required to allow sufficient time for damaged tissue to repair. Based on clinical trials, the following durations are suggested as guidelines. Chronic skin disease: ten to 20 days; chronic cystitis: ten to 28 days; respiratory disease: eight to ten days.|
|Storage||Store below 25°C (air conditioning). Protect from moisture.|
|MSDS (external link)||Clavulox Tablets 50mg MSDS|
|Label (external link)||Clavulox Tablets 50mg Label|
|Manufacturer||Zoetis Australia Pty Ltd|